|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Trading: HOLD @ $3
Signal Strength: STRONG
Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.
Opthea (ASX:OPT) is currently Oversold highlighting the potential for a short term trend reversal in the upward direction. The current level is -28.91% with a current width of 13.65.
The purpose of the Bollinger Bands is to provide a relative definition of high and low. By definition prices are high at the upper band and low at the lower band. This definition can aid in rigorous pattern recognition and is useful in comparing price action of the action of indicators to arrive at systematic trading decision.
Calculation: Bollinger Bands:
1) Middle Band = 20-day simple moving average (SMA);
2) Upper Band = 20-day SMA + (20-day standard deviation of price x 2);
3) Lower Band = 20-day SMA - (20-day standard deviation of price x 2);
PROFILE: Opthea (OPT.AX)
Stock Exchange: ASX
Ticker Codes: | OPT.AX | ASX:OPT |
Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.
|AJX Alexium International||0.06||14||224,969||-13.95||BEARISH|
|UOS United Overseas Australia||0.8||9.6||110,847||-18.29||BEARISH|
|MNS Milnes Holdings||0.08||7.1||959,142||-50.45||BEARISH|
|ALK Alkane Exploration||0.91||6.5||4,762,492||-2.79||BEARISH|
|ABC Adelaide Brighton||3.06||6.3||4,642,840||-28.69||BEARISH|
|RFG Retail Food||0.1||5.4||3,641,364||-19.82||BEARISH|
|FDV Frontier Digital Ventures||1||5.3||159,343||-32.94||BEARISH|